Key terms
About AEMD
Aethlon Medical, Inc. is a medical technology company which focuses on developing products to diagnose and treat life and organ threatening diseases. It develops Aethlon Hemopurifier, which is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. The firm operates through the following segments: Aethlon and ESI. The Aethlon segment is involved in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in 1991 and is headquartered in San Diego, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest AEMD news
Mar 22
5:13pm ET
Aethlon Medical files to sell common stock, warrants, no amount given
Mar 04
6:16am ET
Aethlon Medical price target lowered to $10 from $23 at H.C. Wainwright
Feb 21
8:05am ET
Aethlon Medical announces TA with Santersus
Feb 16
7:57am ET
Maxim Group Sticks to Their Hold Rating for Aethlon Medical (AEMD)
Feb 14
4:20pm ET
Aethlon Medical reports Q3 EPS ($1.37) vs. ($1.24)
No recent press releases are available for AEMD
AEMD Financials
Key terms
Ad Feedback
AEMD Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
AEMD Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
